Efficacy and Safety in Patients With Chronic Lymphocytic Leukemia (CLL) Treated With Idelalisib and Rituximab in the Clinical Practice: a GIMEMA-ERIC Study
Clinical trial NCT03545035 · COMPLETED
Trial details
- NCT number
- NCT03545035
- Sponsor
- Gruppo Italiano Malattie EMatologiche dell'Adulto
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2019-02-06
- Primary completion
- 2020-10-28
- Enrollment
- 104
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.